Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU studies Apollo/Taminco deal

The European Commission has invited comments on the proposed acquisition of Belgian chemical company Taminco (Ghent) by US investment company Apollo Global Management for some €1,100 million ($1,406 million). A preliminary examination indicates that the deal may come within the scope of the EU Merger Regulation, the Commission says. UK-based global private equity firm CVC (London) is selling the 75% stake in Taminco that it purchased in 2007 ( Agrow No 524, p 1). The Belgian company is the world’s largest producer of alkylamines and derivatives, which are used as intermediates in the manufacture of agrochemicals. Apollo invests across a wide range of industries, including chemicals.

Topics

What to read next

UsernamePublicRestriction

Register

AG005702

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel